No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV

By afschroeder • June 18, 2025

Erlandson KM, McKhann A, Kitch DW, Palella FJ, Ellis RJ, Ances BM, Zanni MV, Diggs MR, Chu SM, Currier JS, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Aberg JA, Koletar SL, Presti RM, Hatlen TJ, Skiest DJ, Douglas PS, Ribaudo HJ, Grinspoon SK. No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV. AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004267. Epub ahead of print. PMID: 40528406.

Tags: Dementia, Harbor UCLA, HIV, Infectious Diseases, neurocognition, Publications, Randomized clinical trial, statin

Recurrent mutations in the stress regulator Cap1 reveal a trade-off between azole resistance and oxidative stress response in Candida albicans

Zhou X, Hilk A, Solis NV, Scott N, Zajac C, Filler SG, Selmecki A. Recurrent mutations in the stress regulator Cap1 reveal a trade-off between[...]

Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis

Karpouzas GA, Pascual-Ramos V, Gonzalez-Gay MA, Misra DP, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Galarza-Delgado D, Van Riel P, Semb AG,[...]

Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis

Pikoulas A, Morianos I, Nidris V, Hamdy R, Intze E, López-López Á, Moran-Garrido M, Muthu V, Halabalaki M, Papaioanou V, Papadovasilaki M, Kyrmizi I, Gu[...]